⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NMRA News
Neumora Therapeutics, Inc. Common Stock
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898
globenewswire.com
NMRA
Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model
globenewswire.com
NMRA
Neumora Therapeutics to Host Virtual R&D Day on October 27
globenewswire.com
NMRA